Valacyclovir: Affected Lot May Contain Tablets Intended For European Market (different Embossement)

Valacyclovir Recall Summary Certain lots of valacyclovir tablets distributed across Canada may contain tablets that were made for the European market and have different markings than intended. This is a Class I safety recall, meaning there is a potential serious health risk. The recall affects valacyclovir products distributed throughout Canada.

Product
VALACYCLOVIR
Reason
Product safety
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2024-08-27
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/03ab041c-3e19-4f9e-a11a-374b8ed79f6f